It has also been reported that ADRB2 interferes with the autophagy of the Beclin1/VPS34/Atg14 complex in hepatocellular carcinoma, resulting in the reprogramming of glucose metabolism and the acquisition of sorafenib resistance (31). This evidence concerns the gene ADRB2 and hepatocellular carcinoma.